openPR Logo
Press release

Pharmacogenomics Market worth $5.8 billion by 2028

04-08-2024 09:28 PM CET | Health & Medicine

Press release from: ABNewswire

Pharmacogenomics Market in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to 2028 according to a new report by MarketsandMarkets™

North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to 2028 according to a new report by MarketsandMarkets Trademark . The increasing focus on the translational approach to optimize drug development processes, increasing collaborations and partnerships between key players and research institutes, and rising incidence of cancer are the major driving factors of the pharmacogenomics market. However, concern regarding drug response variability, and challenges in data integration and interpretation are the major restraining factors of the pharmacogenomics market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=142682251 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=142682251&utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral]

The kits & reagents segment accounted for the largest share by product & service in the pharmacogenomics market in 2022.

By product & service, the pharmacogenomics market has been further categorized kits & reagents and service. Kits & reagents accounted for the largest share of the pharmacogenomics market in 2022. The pivotal role played by kits and reagents in the execution of pharmacogenomic tests, combined with the rising adoption of personalized medicine and advancements in genomic technologies, contributes significantly to the expansion of this segment within the pharmacogenomics market.

The sequencing segment is expected to grow at a higher rate during the forecast period.

Based on technology, the pharmacogenomics market has been segmented into sequencing, PCR, microarray, and other technologies. In 2022, the sequencing segment accounted for the largest share of the pharmacogenomics market is expected to grow at a higher growth rate during the forecast period of 2023-2028. Sequencing technologies play a crucial role in precisely and effectively handling genomic data, facilitating the identification of nucleotide alterations impacting drug metabolism and response. The progress in developing novel sequencing technologies and reagents further propels the evolution of pharmacogenomics research, facilitating the identification and functional understanding of genetic variants associated with drug metabolism and response.

The cancer segment accounted for the largest share of the disease area segment in the pharmacogenomics market in 2022.

Based on disease area, the pharmacogenomics market has been segmented into cancer, cardiovascular, neurological diseases, and other diseases. In 2022, the cancer segment accounted for the largest share of the pharmacogenomics market. The expansion of the pharmacogenomics market is fueled by a surge in research funding dedicated to the advancement of personalized drug products for cancer treatment. For instance, the National Cancer Institute (NCI) allocated an estimated USD 6,467 million from its research budget, covering diverse disease areas such as AIDS, brain & CNS, and cancer.

The North America region accounted for the largest share of the pharmacogenomics market in 2022.

The pharmacogenomics market is segmented into North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), and the Middle East and Africa (MEA). The North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.

Request Sample Pages: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=142682251 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=142682251&utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral]

Pharmacogenomics Market Dynamics:

Drivers:

1. Growing incidence and prevalence of chronic and genetic diseases

2. Rising investments and funding to support genomic projects

3. Rising incidence of cancer

4. Increasing collaborations and partnerships between key players and research institutes

5. Increasing focus on translational approach to optimize drug development processes

Restraint:

1. Challenges in data integration and interpretation

2. Issues related to drug response variabilities

Opportunities:

1. Use of genomics in specialized/personalized medicine

2. AI in pharmacogenomics

3. Increasing cost-effectiveness of pharmacogenomics testing

Challenge:

1. Ethical and regulatory hurdles

2. Growing concerns related to patient privacy and data access

Key Market Players of Pharmacogenomics Industry:

Key players in the pharmacogenomics market Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Laboratory Corporation of America Holdings (US), Charles River Laboratories (US), Eurofins Scientific (Luxembourg), Bio-Rad Laboratories, Inc. (US), Agilent Technologies, Inc. (US), BD (US), QIAGEN (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity (US), IQVIA Inc. (US), Mesa Labs, Inc. (US), Medpace (US), MGI Tech Co., Ltd. (China), Takara Bio Inc. (Japan), PacBio (US), New England Biolabs (US), BGI (China), Novogene Co., Ltd. (China), SOPHiA GENETICS (Switzerland), Fios Genomics (UK), Personalis, Inc. (US), BioAI Health Inc. (US), NeoGenomics Laboratories (US), and Macrogen, Inc. (South Korea).

The primary interviews conducted for this report can be categorized as follows:

* By Respondent: Supply Side- 70% and Demand Side 30%
* By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
* By Region: North America -30%, Europe -20%, Asia-Pacific -30%, Latin America -15% and Middle East & Africa- 5%

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=142682251 [https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=142682251&utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral]

Pharmacogenomics Market - Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmacogenomics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=pharmacogenomics-market-worth-58-billion-by-2028]
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacogenomics Market worth $5.8 billion by 2028 here

News-ID: 3456531 • Views: …

More Releases from ABNewswire

Xtinio Expands Service Portfolio in Austin, Introducing Comprehensive Digital Solutions for Small Businesses
Xtinio Expands Service Portfolio in Austin, Introducing Comprehensive Digital So …
Xtinio Consulting (www.xtinio.com) is a professional business services and digital marketing agency dedicated to helping companies scale with innovative strategies, creative execution, and measurable results. Xtinio Consulting, a fast-growing business solutions and digital marketing agency, announced today the expansion of its service portfolio in Austin, Texas. The company is rolling out a suite of new digital solutions designed to empower small and medium-sized businesses (SMBs) with the tools they need to…
Top Real Estate Agent in Cedar City, UT Sees Growing Preference for Consultation-Based Service Over Traditional Sales Approaches
Top Real Estate Agent in Cedar City, UT Sees Growing Preference for Consultation …
Cedar City, UT - The real estate industry is experiencing a significant shift as homebuyers increasingly seek authentic consultation over traditional high-pressure sales tactics. Matt Bagley, a seasoned professional who began his business career in 2005, has observed this trend firsthand and has built his practice around serving clients as a trusted advisor rather than a conventional salesperson. "Nothing is more of a turnoff than someone that comes across as a…
Support Grows for Steven L. Sykes Amid Prostate Cancer Surgery and Recovery Challenges
Support Grows for Steven L. Sykes Amid Prostate Cancer Surgery and Recovery Chal …
Richmond, VA - 03 Oct, 2025 - The Richmond community and beyond are uniting to support Steven L. Sykes, also known as MR. LP, a respected media professional, advocate, and founder of Enliven Global Media. Steven recently underwent a radical prostatectomy on September 22 to treat prostate cancer. Following the procedure, he faced serious post-surgical complications, including a blockage in his kidneys that required a robotic right ureteral reimplantation and…
Remodify Trademark Named Best of Tech Ohio Honoree, Defining Tradestech Trademark in Home Services and Improvement From the Heart of Northeast Ohio
Remodify Trademark Named Best of Tech Ohio Honoree, Defining Tradestech Trademar …
CLEVELAND - October 3, 2025 - Remodify [https://www.remodify.io/], a technology company redefining how contractors and homeowners work together in the home services and improvement market, has been named a 2025 Best of Tech Ohio Honoree. Headquartered and building in Northeast Ohio, Remodify is leading the rise of Tradestech, a new category of tools built for and by the skilled trades. Remodify's platform gives contractors and home service providers AI-powered tools to…

All 5 Releases


More Releases for America

Stabilit America Highlights Applications of Fiberglass Roof Panels with Stabilit …
Roofing materials are very important in the realm of modern construction, as they should be long lasting, economical and attractive. Fiberglass roof panels are a few of the numerous choices among several alternatives that have received a reputation of being versatile, long life, and adaptable in various sectors. They are favored by the architects, contractors, and property developers due to their lightweight construction, resistance to weather factors, and the ease…
Deodorants Market Report by Region (North America, EMEA, Latin America, Asia)
2025 - Pristine Market Insights, a leading market research firm, announced the release of its latest and comprehensive market research report on Deodorants market. The report spans over 500 pages and delivers 10-year market forecast in US dollars (or custom currencies upon request). It provides in-depth analysis of market dynamics (drivers, opportunities, restraints), PESTLE insights, latest industry trends, and demand factors. The report includes segmented market value, share (%), compound…
Sequestrant Market Report by Region (North America, EMEA, Latin America, Asia)
2025 - Pristine Market Insights, a leading market research firm, announced the release of its latest and comprehensive market research report on Sequestrant market. The report spans over 500 pages and delivers 10-year market forecast in US dollars (or custom currencies upon request). It provides in-depth analysis of market dynamics (drivers, opportunities, restraints), PESTLE insights, latest industry trends, and demand factors. The report includes segmented market value, share (%), compound…
Buttermilk Market Study by Region (North America, Latin America, Europe, Asia, M …
2025 - Pristine Market Insights, a leading market research firm, announced the release of its latest and comprehensive market research report on Buttermilk market. The report spans over 500 pages and delivers 10-year market forecast in US dollars (or custom currencies upon request). It provides in-depth analysis of market dynamics (drivers, opportunities, restraints), PESTLE insights, latest industry trends, and demand factors. The report includes segmented market value, share (%),…
Textiles Market Analysis Report, Regional Outlook - Europe, North America, South …
Adroit Market Research has announced the addition of the “Global Textiles Market Size Status and Forecast 2025”, The report classifies the global Textiles in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report studies the global Textiles Speaker market, analyzes and researches the Textiles Speaker development status and forecast in Europe, North America, Central America, South America, Asia Pacific…
Global Gaucher Disease Market 2018 Covering North America, South America, Europe
Gaucher Disease Market Summary The Global Gaucher Disease Market is defined by the presence of some of the leading competitors operating in the market, including the well-established players and new entrants, and the suppliers, vendors, and distributors. The key players are continuously focusing on expanding their geographic reach and broadening their customer base, in order to expand their product portfolio and come up with new advancements. Gaucher Disease market size to maintain the average annual growth…